Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mazindol ER by NLS Pharmaceutics for Type 1 Narcolepsy (Narcolepsy with Cataplexy): Likelihood of Approval
Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Type 1 Narcolepsy (Narcolepsy with...
Data Insights
Mazindol ER by NLS Pharmaceutics for Type 2 Narcolepsy (Narcolepsy without Cataplexy): Likelihood of Approval
Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Type 2 Narcolepsy (Narcolepsy without...